(1) Procedures pursuant to Article 5 (c), Article 6, Article 10 (8) and Article 16 (1) and (4) of Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems (OJ L 157, 9.6.2006, p. 1) are initiated by way of action in accordance with section 81 (1) sentence 1.
(2) Sections 81 to 85 apply accordingly, unless the proceedings are determined by Regulation (EC) No 816/2006.
3. Common procedural provisions